logo
Plus   Neg
Share
Email

Lilly To Present Data Across Its Oncology Product Portfolio

Eli Lilly and Co. (LLY) said that it will present data from a number of studies across its oncology product portfolio at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, September 27 - October 1, 2019.

Lilly said it continues to investigate Verzenio (abemaciclib) across the breast cancer continuum to provide physicians with the information they need as they seek to optimize treatment options for those living with this devastating, complex disease.

In a late-breaking oral presentation, Lilly will share the registrational results of selpercatinib (LOXO-292) in RET-altered thyroid cancers, from the Phase 1/2 LIBRETTO-001 study.

Selpercatinib is a highly selective and potent, oral investigational new medicine being studied for the treatment of advanced cancers that develop due to alterations of the RET kinase.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford plans to bring back the Bronco as a dedicated off-road brand when it launches an all-new 4x4 SUV lineup on July 13. The automaker said it will introduce an all-new Bronco brand under the tagline, "Built Wild". The new lineup includes two-door and four-door models of the Bronco as well as the Bronco Sport compact SUV. J. M. Smucker Co. is recalling certain Natural Balance canned cat food, citing health concerns likely associated with increased levels of choline chloride, an animal growth promotant, the U.S. Food and Drug Administration said in a statement. The recall was initiated after receiving reports of adverse reactions. Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles.
Follow RTT